LRRK2 Mutation and Parkinson's Disease

Clinical trial NCT01424475 · TERMINATED

Trial details

NCT number: NCT01424475
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2011-08-11
Primary completion: 2015-01-12
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.